Why Global Life Sciences Companies Are Choosing India for Strategic Value Creation

  • June 16, 2026

India is rapidly emerging as a strategic growth engine for the global life sciences industry becoming a hub for digital R&D, regulatory science, advanced research and manufacturing, analytics, and innovation. As global pharmaceutical, biotechnology, medtech, CRO, and CDMO organizations expand their footprint, India is increasingly playing a central role in value creation, operational resilience, and scientific advancement.

This whitepaper explores the structural drivers behind India’s rise, including its talent ecosystem, manufacturing strength, regulatory credibility, innovation clusters, and supportive policy environment.

Download the full whitepaper to learn more.